| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.7M | +146.7% |
| R&D Expense | $41.3M | -22.1% |
| SG&A Expense | $70.1M | +69.8% |
| Operating Income | -$110.5M | +18.2% |
| Pre-tax Income | -$250.6M | -95.8% |
| Income Tax | $3K | +100.2% |
| Net Income | -$250.6M | -98.6% |
| EPS (Basic) | -$1.37 | -191.5% |
| EPS (Diluted) | -$1.37 | -191.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $30.2M | +2.4% |
| Short-term Investments | $67.6M | -1.1% |
| Accounts Receivable | $3.9M | +322.9% |
| Inventory | $9.6M | — |
| Current Assets | $115.2M | +12.5% |
| Total Assets | $155.5M | +7.0% |
| Current Liabilities | $37.3M | +73.4% |
| Long-term Debt |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$87.8M | -28.8% |
| Capital Expenditures | $2.0M | -76.8% |
| Investing Cash Flow | -$1.5M | +92.6% |
| Financing Cash Flow | $90.0M | -18.6% |
| Free Cash Flow | -$89.8M | -17.0% |
| $93.2M |
| — |
| Total Liabilities | $134.6M | +71.4% |
| Stockholders' Equity | $20.9M | -45.7% |